| Breakdown | TTM | Mar 2026 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.21B | 256.01B | 148.41B | 115.18B | 113.48B | 100.06B |
| Gross Profit | 75.89B | 75.21B | 61.85B | 55.44B | 54.55B | 50.62B |
| EBITDA | 13.51B | 12.80B | 8.24B | 5.60B | 6.24B | 8.91B |
| Net Income | 4.03B | 3.64B | 4.11B | 1.81B | 2.73B | 5.03B |
Balance Sheet | ||||||
| Total Assets | 136.74B | 134.56B | 143.71B | 64.50B | 52.63B | 38.36B |
| Cash, Cash Equivalents and Short-Term Investments | 20.98B | 19.16B | 29.65B | 14.78B | 13.07B | 15.58B |
| Total Debt | 50.17B | 52.09B | 51.73B | 22.16B | 13.80B | 1.35B |
| Total Liabilities | 96.48B | 95.07B | 106.31B | 38.36B | 28.76B | 18.36B |
| Stockholders Equity | 31.07B | 30.46B | 29.09B | 24.60B | 22.13B | 19.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 944.00M | 5.56B | 4.08B | -1.27B | 7.79B |
| Operating Cash Flow | 0.00 | 3.50B | 7.18B | 5.31B | 924.00M | 8.82B |
| Investing Cash Flow | 0.00 | -11.59B | -10.62B | -12.10B | -3.21B | -2.03B |
| Financing Cash Flow | 0.00 | -2.42B | 18.07B | 8.23B | -264.00M | 1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥163.41B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥15.78B | 2.44 | ― | 3.17% | 5.19% | 11.04% | |
62 Neutral | ¥137.53B | 14.71 | ― | 3.02% | 2.16% | -24.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥50.62B | 3.77 | ― | 0.52% | 20.97% | -56.39% | |
60 Neutral | ¥12.09B | 7.69 | ― | 4.65% | 4.62% | -56.98% | |
58 Neutral | ¥71.70B | 15.39 | ― | 1.48% | 8.41% | -3.65% |